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S
houlder arthroscopy is currently one of the more common orthopaedic procedures, with an estimated 1.4 million procedures performed per year worldwide 1 . Many of these procedures are being performed on an outpatient basis and present substantial postoperative pain control challenges to the surgeon and anesthesiologist. An integral component of successful ambulatory surgical treatment is achieving and maintaining adequate pain management during the early postoperative course.
The pain during the first twenty-four to forty-eight hours after arthroscopic shoulder surgery is often equivalent to that after open surgery, with 30% of patients reporting severe pain on the first postoperative day 2 . In a study of more than 15,000 outpatient surgical procedures from nine different surgical specialties, pain was responsible for 12% of the unplanned postoperative hospital admissions 3 . A retrospective review of 222 shoulder arthroscopy cases revealed a 2% rate of unplanned overnight admission because of pain symptoms 4 . Additionally, postoperative pain may instigate endocrine and metabolic responses, autonomic reflexes, nausea, and constipation that potentially lead to delayed postoperative rehabilitation, adhesive capsulitis, hospital admission, and loss of work days [5] [6] [7] . As a result, many different modalities have been described in both the orthopaedic and anesthesiology literature to minimize postoperative pain following ambulatory surgery 8 . Traditionally, these surgical procedures were performed under general anesthesia with infiltration of local anesthetic and parenteral administration of opioids to achieve early postoperative pain relief. Over forty years ago, Winnie reported the results of an interscalene brachial plexus block involving a single anesthetic injection for pain control following shoulder surgery 9 . Nearly two decades later, Tuominen et al. described an interscalene block technique involving the placement of an indwelling catheter to provide continuous infusion of anesthetic for two to three days of pain relief 10 . A third modality includes continuous anesthetic administration via a pump catheter placed into the subacromial or intraarticular space [11] [12] [13] . There is a relative paucity of high-level randomized controlled studies addressing the benefits and potential complications associated specifically with interscalene brachial plexus blocks. The purpose of the present systematic review was to evaluate the available Level-I and II randomized controlled trials comparing interscalene blocks in arthroscopic shoulder surgery with placebo or noncontinuous infusion of anesthetic, with the primary outcome being analgesic efficacy. Secondary outcomes included use of narcotic and non-narcotic medication, side effects of opioid use, costeffectiveness, and complications of the interscalene block. We hypothesized that the interscalene block would be at least as effective as general anesthesia alone or other regional anesthetic techniques for decreasing postoperative pain, the need for supplemental analgesics, and episodes of nausea and vomiting, and that the associated complication rate would be low.
Materials and Methods

W
e performed an electronic search of PubMed (1950 to present), Embase (1966 to present), and the Cochrane databases with use of the following search terms: ''shoulder arthroscop* AND (block OR regional anesthesia),'' ''rotator cuff AND (block OR regional anesthesia),'' and ''interscalene.'' This search was performed on May 28, 2012, and identified 1049 articles in PubMed, 1630 articles in Embase, and no articles in the Cochrane library database. The search results represented a total of 1350 unique articles after removal of Disclosure: None of the authors received payments or services, either directly or indirectly (i.e., via his or her institution), from a third party in support of any aspect of this work. One or more of the authors, or his or her institution, has had a financial relationship, in the thirty-six months prior to submission of this work, with an entity in the biomedical arena that could be perceived to influence or have the potential to influence what is written in this work. No author has had any other relationships, or has engaged in any other activities, that could be perceived to influence or have the potential to influence what is written in this work. The complete Disclosures of Potential Conflicts of Interest submitted by authors are always provided with the online version of the article.
Source of Funding
There was no external funding source for this study.
Results
T ables I and II summarize the study demographics, including the outcome measures used and potential sources of bias. Table III summarizes the study randomization and blinding process and power analysis. Table IV summarizes the analgesia protocols, which included oral and parenteral administration of narcotics and non-narcotics and local infiltration of anesthetics. A meta-analysis was not believed to be appropriate because of the wide variations in the nature of the control and treatment groups across the studies and the heterogeneity of the outcome measures used.
Use of an interscalene block was associated with a significant reduction in the pain level, as measured with use of a visual analog scale (VAS) or a visual eleven-point box scale (BS-11), at various time points up to twenty-four hours after surgery in each of the ten studies included in the systematic review [15] [16] [17] [18] [19] [20] [21] [22] [23] [24] . VAS and BS-11 pain scores were significantly lower than those in the controls at twenty-four hours after surgery in three of the seven studies that included this time point 17, 21, 24 . Lee et al. and Nisar et al. reported significantly lower VAS scores at all time points less than twelve hours after surgery but not at twenty-four hours 20, 22 . Oh et al. reported lower VAS scores at one hour and eight hours after surgery in the group that received a single-injection interscalene block compared with the control group that received intravenous pain medication 23 . Laurila et al. found that use of an interscalene block significantly lowered the BS-11 score at rest during the first four hours after surgery as well as the score when the patient moved the arm during the first six hours 19 . DeMarco et al. conducted a double-blind study of fifty-three patients who received a subacromial continuous infusion of bupivacaine combined with an interscalene injection of either 0.5% ropivacaine or a saline solution control. The VAS score in the patients who received the ropivacaine interscalene block was significantly lower during the first six hours but not at subsequent time points (up to eighty hours) 16 . In addition, the amount of supplemental analgesia required was significantly less in the interscalene block group compared with the control group at various postoperative time points in eight of the nine studies that examined this outcome 15, 17, [19] [20] [21] [22] [23] [24] . The type of supplemental analgesia varied across the studies. Only the study by Gonano et al. did not record the administration of supplemental medication in the treatment and control groups 18 . It should be noted that both the VAS and supplemental analgesic outcomes could be susceptible to subject bias as the patients in most of the studies were aware of whether they had received an interscalene block or another form of treatment. Only the studies by Al-Kaisy et al. and DeMarco et al. had true double-blinding between the control and treatment groups 15, 16 . In both of those studies, the VAS score was approximately 50% lower in the group that received an interscalene block with anesthetic compared with the group that received saline solution. In the study by Al-Kaisy et al., the amount of supplemental analgesia needed was approximately one-third as great in the group that received an interscalene block with anesthetic compared with the group that received saline solution 15 . The study by DeMarco et al. revealed a trend toward lower oral narcotic usage in the interscalene block group, although the difference did not reach significance 16 . One of the proposed benefits of regional anesthesia is a decrease in systemic complications such as nausea and vomiting. The prevalence of nausea and vomiting was reported in eight of the ten studies included in this review 15, 17, [19] [20] [21] [22] [23] [24] . Only two of the eight studies revealed a significant difference between the interscalene block and control groups, with less nausea and vomiting reported in the interscalene block group in each case 15, 24 . It is possible that the remaining six studies failed to reveal a significant difference because of a type-II sampling error, as each of the studies that included a power analysis was designed to achieve adequate power for the VAS score or supplemental analgesic usage rather than the prevalence of nausea and vomiting.
The overall complication rate attributable to the interscalene block was low. Horner syndrome was noted in six patients in the included studies, with five of these being in one study 18, 21 . Only one hematoma was reported 21 , and one case of persistent hand paresthesia resolved after twenty-four hours 15 . Four cases of mild dyspnea and two cases of dysphonia were noted in the interscalene block group in one study 17 . A potential observer bias for these blinded-evaluator studies resulted from the inability of the evaluator to definitively determine failure or success of the block as the allocation group was not known at the time of the evaluation.
Discussion
T his systematic review was performed to analyze the available evidence from high-quality studies in order to evaluate our hypothesis that an interscalene block was at least as effective as general anesthesia alone or other regional anesthetic techniques in decreasing postoperative pain, the need for supplemental analgesics, and episodes of nausea and vomiting. Additionally, we attempted to document the prevalence of complications associated with the interscalene block. Our evaluation of the available Level-I and II evidence indicates that use of an interscalene block in shoulder arthroscopy resulted in a significant reduction in the pain level and the need for supplemental analgesics compared with general anesthesia and other regional anesthetic techniques. Nausea and vomiting may have been reduced by the interscalene block in two studies, but the remaining six studies did not support this claim. There were relatively few reported complications in the included studies, and most of these complications were transient.
An interscalene block can be performed by means of a single injection of anesthetic or by placement of an indwelling catheter and anesthetic pump. We decided to limit this review to include only comparisons between an interscalene block and a placebo or noncontinuous infusion of anesthetic for two reasons: (1) interscalene blocks are one of the most common regional anesthesia techniques utilized, and (2) such a restriction limits the heterogeneity of the interventions reviewed 25 .
We also decided to exclude studies that utilized intra-articular anesthetic delivery devices as use of such devices has been associated with the development of glenohumeral joint chondrolysis after arthroscopy [26] [27] [28] . This review did not include articles that compared a single-injection interscalene block with a continuous interscalene block. However, such a comparison has been made in a randomized study by Fredrickson et al. involving sixty-one patients undergoing subacromial decompression, distal clavicular excision, or labral repair. Patients were randomized by computer to either an intraoperative interscalene block with 0.5% ropivacaine or a continuous interscalene block for a total of forty-eight hours. Those authors found that the continuous interscalene block resulted in significantly lower levels of pain and supplemental analgesic usage during the first postoperative day compared with the single-injection interscalene block 29 . An identified weakness of this systematic review is the heterogeneity in the preoperative and postoperative protocols and in the shoulder pathology that was being treated. None of the ten studies exactly matched another study with regard to the anesthetic medication, medication concentration, or volume infused. 1321 Subject bias as patients as patients were not blinded to their group allocation since controls received no placebo injection *NM = not mentioned, VAS = visual analog scale, SD = standard deviation, ISBP = interscalene brachial plexus block, SUB = subacromial bursa blockade, PCA = patient-controlled analgesia, and IV = intravenous.
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T 17, 2013 Fortunately, the interscalene block in all ten studies was performed with use of a neurostimulator for guidance, thus avoiding a further source of heterogeneity; however, the use of ultrasonographically guided interscalene blocks is becoming increasingly popular 30, 31 . Finally, a power analysis was not mentioned as a part of the design of four of the ten studies in this review. The remaining six studies that did include a power analysis varied with regard to the variable on which the power analysis was based [16] [17] [18] [19] 22, 24 . This heterogeneity introduces the potential for type-II (beta) errors for variables for which no statistically significant difference was found (i.e., the need for supplemental medication 16 and the occurrence of nausea 17, [19] [20] [21] [22] [23] ). Since arthroscopic shoulder procedures are now often performed on an outpatient basis, interventions such as regional anesthesia, which decrease postoperative pain as well as nausea and vomiting and have a low complication rate [32] [33] [34] [35] [36] , can potentially decrease the need for unexpected hospital admission, unwanted medical complications related to surgery, and overall health-care costs. Use of an interscalene block can also increase patient satisfaction after arthroscopic shoulder surgery 15, 17, 24 . Lastly, Gonano et al. found that use of an interscalene block for patients undergoing arthroscopic shoulder surgery reduced total costs, improved the anesthesia-related work flow, decreased the time spent in the post-anesthesia care unit, and decreased the time spent in the operating room 18 . These factors will become more important with the implementation of performance benchmarks as part of the Patient Protection and Affordable Care Act 37 . 
General
Morphine NM *IV = intravenous, IM = intramuscular, subq. = subcutaneous, NM = not mentioned, bupi = bupivacaine, ISBP = interscalene brachial plexus block, and PCA = patient-controlled analgesia. 17, 2013 In conclusion, use of an interscalene brachial plexus block resulted in significant decreases in postoperative pain scores and in the amount of supplemental analgesia required in patients undergoing arthroscopic procedures involving the shoulder. The interscalene block had no clear benefit with regard to decreasing nausea. The overall complication rate attributable to the block was negligible. Interscalene brachial plexus blocks were cost-effective compared with general anesthesia alone. n
